NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Genetics & Environmental Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genetics & Environmental Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



B-Cell Lymphoma Immunology



New findings from Kyoto University in the area of B-cell lymphoma immunology described



November 22nd, 2007

Data detailed in 'Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice' have been presented. "LYL1, a member of the class II basic helix-loop-helix transcription factors, is aberrantly expressed in a fraction of human T-cell acute lymphoblastic leukemia. Here, we generated transgenic mice ubiquitously overexpressing LYL1 using a construct expressing full-length cDNA driven by a human elongation factor 1alpha promoter," scientists in Kyoto, Japan report.

"Four independent lines exhibiting high LYL1 expression were established. Of these transgenic mice, 96% displayed loss of hair with a short kinked tail. Furthermore, 30% of them developed...


Source: Genetics & Environmental Business Week (2007-11-22)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login